The Special Drug Use-results Survey on Long-term Use of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed Dose Combination Tablets in Patients With Hypertension
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Amlodipine/telmisartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 05 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Oct 2017 Planned number of patients changed from 500 to 600.
- 21 Jul 2017 Planned number of patients changed from 550 to 500.